The Global Health Body Issues Concern Over Acute Shortage of Obesity Injections

Less than one in 10 people eligible to benefit from obesity jabs like Wegovy are able to get them, states the WHO as it issues its first advice on the therapies.

With in excess of 1,000,000,000 individuals worldwide now obese, it is advocating for broader and more equitable availability to these injectable treatments.

Based on estimates, in excess of 2,000,000,000 will be living with obesity by 2030 if no action is taken.

"The latest guidelines affirms that excess weight is a long-term condition that can be managed with thorough and continuous care," stated the agency's head Tedros Adhanom Ghebreyesus.

Significant expense, constrained manufacturing, and distribution challenges are significant hurdles to universal access to the injections that can aid individuals in losing considerable body mass, explains the organization.

Skinny Jab Supply Crisis

Even under the current most favorable outlook, the supply of these medications would only suffice for around 100 million people – fewer than 10% of those who need them, according to the WHO.

The advice urges countries and companies to expand availability, through measures including licensing agreements.

Exclusive production rights on semaglutide – the core component of Novo Nordisk's Wegovy – is due to expire in several countries in 2026.

The Way Obesity Injections Function

These medications replicate a body's own hormone to reduce digestion speed, suppress the appetite and enhance satiety so people consume fewer calories.

Patients commonly begin shedding pounds within a few weeks of beginning the regular doses.

Studies indicates patients may put most of the weight back on within a year of halting the treatment, as their usual appetite resume.

Being carrying excess weight increases your risk for developing medical conditions, including type 2 diabetes, heart disease, brain attack, and some cancers.

Excess weight impacts people in countries worldwide and was linked to over three and a half million fatalities worldwide in 2024, per the health agency.

Christopher Johnson
Christopher Johnson

A seasoned space gambler and cosmic casino reviewer with a passion for interstellar risk-taking and strategy analysis.